Review: incidence and clinical significance of Bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancer.
about
Circulating Tumor DNA as Biomarkers for Cancer Detection.Effect of an anti-human Co-029/tspan8 mouse monoclonal antibody on tumor growth in a nude mouse model.Liquid biopsy: monitoring cancer-genetics in the blood.BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis.Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessationA comparison of epithelial-to-mesenchymal transition and re-epithelializationBreast Cancer Biomarkers: Utility in Clinical Practice.Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma.Anti-angiogenic therapy: concept to clinic.Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection.The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40.A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy.Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases.Tracheomediastinal Fistula: Rare Complication of Treatment with Bevacizumab.
P2860
Q33632125-BAEA509E-B066-4C78-AC0D-21DA8B2BB7A7Q34211752-EFC952AB-2B24-43B9-B57D-A83B3D54BAC7Q34356149-5B8FA351-87AF-4D8F-A0C3-632285D073B6Q35870363-770D5B62-C858-4CE4-BF86-3FC1989C1E6CQ36299062-C038EB41-90E6-4930-9673-5E38BB37AA73Q36678367-A9041123-1857-4F00-BD47-CF884A3E59B8Q37441159-A789530A-8A5E-4AF3-B7EE-AF375323CBF4Q37551463-4BD584E8-E086-4FC4-AA8E-6B6A636C9F95Q37955304-E972D50F-B436-47FA-A93F-F2E124A5D9E4Q38893852-B4D4B898-F203-4935-A9A9-328A2E523854Q45047438-CE184CF5-6222-4FC2-B210-DAA706F85D28Q48252313-2CD23934-35D1-4784-8047-96ACD186F134Q55094789-223D0B86-A634-4CB0-82F2-9EB8BEB7E798Q55249526-CB9F31BC-1B00-4044-9C42-0EA47C2E3E87
P2860
Review: incidence and clinical significance of Bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Review: incidence and clinical ...... metastatic colorectal cancer.
@en
Review: incidence and clinical ...... metastatic colorectal cancer.
@nl
type
label
Review: incidence and clinical ...... metastatic colorectal cancer.
@en
Review: incidence and clinical ...... metastatic colorectal cancer.
@nl
prefLabel
Review: incidence and clinical ...... metastatic colorectal cancer.
@en
Review: incidence and clinical ...... metastatic colorectal cancer.
@nl
P1476
Review: incidence and clinical ...... metastatic colorectal cancer.
@en
P2093
P304
P356
10.1016/J.EJSO.2011.06.004
P577
2011-07-20T00:00:00Z